3-(5-phenyl-1-propionyl-4,5-dihydro-1H-pyrazol-3-yl)-2H-chromen-2-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 香豆素及其衍生物
• 英文名称: 3-(5-phenyl-1-propionyl-4,5-dihydro-1H-pyrazol-3-yl)-2H-chromen-2-one
• 英文别名: 3-(3-coumarinyl)-5-phenyl-1-propionyl-2-pyrazoline；3-(3-Phenyl-2-propanoyl-3,4-dihydropyrazol-5-yl)chromen-2-one
• 化学式: C₂₁H₁₈N₂O₃
• 分子量: 346.386
• InChiKey: ACIQALGPUWKCIP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  26
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  59
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  3-cinnamoyl-2H-chromen-2-one 在 4-二甲氨基吡啶 、 一水合肼 作用下， 以 乙醇 、 氯仿 为溶剂， 反应 8.0h， 生成 3-(5-phenyl-1-propionyl-4,5-dihydro-1H-pyrazol-3-yl)-2H-chromen-2-one
  参考文献：
  名称：

  Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo

  摘要：

  It is of our interest to generate and identify novel compounds with regulation telomerase for cancer therapy. In order to carry out more rational design, based on structure-based drug design, several series of N-substituted-dihydropyrazole derivatives, totally 78 compounds as potential human telomerase inhibitors were designed and synthesized. The results demonstrated that some compounds had potent anticancer activity against four tumor cell lines, and showed good selectivity on tumor cells over somatic cells. By the modified TRAP assay, compound 13i exhibited the most potent inhibitory activity against telomerase with an IC50 value of 0.98 mu M. In vivo evaluation results indicated that compound 13i could inhibit growth of S180 and HepG2 tumor-bearing mice, and it also significantly enhanced the survival rate of EAC tumor-bearing mice. The further results in vivo confirmed that it could significantly improve pathological changes of N,N-diethylnitrosamine (DEN)-induced rat hepatic tumor. These data support further studies to assess rational design of more efficient telomerase inhibitors in the future. (C) 2016 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2016.02.009

文献信息

• Synthesis of 1-substituted 5-aryl-3-(3-coumarinyl)-2-pyrazolines by the reaction of 3-aryl-1-(3-coumarinyl)propen-1-ones with hydrazines
  作者：Albert Lévai、Jozsef Jekö、D. I. Brahmbhatt

  DOI：10.1002/jhet.5570420633

  日期：2005.9

  1-Acetyl- and 1-propionyl-2-pyrazolines 11-27 have been synthesized by the reaction of (3-coumarinyl)chalcones 1-10 with hydrazine in hot acetic acid or propionic acid. While 5-aryl-3-(3-coumarinyl)-1-phenyl-2-pyrazolines 28-35 have been prepared by the reaction of (3-coumarinyl)chalcones 1,3,5-10 with phenylhydrazine in hot pyridine. Structures of all new compounds have been elucidated by microanalyses

  1-乙酰基和1-丙酰基-2-吡唑啉11-27是通过（3-香豆基）查耳酮1-10与肼在热乙酸或丙酸中的反应合成的。虽然5-芳基-3-（3-香豆基）-1-苯基-2-吡唑啉28-35是通过（3-香豆基）查尔酮1,3,5-10与苯肼在热吡啶中的反应制备的。所有新化合物的结构已通过微量分析，1 H和13 C nmr光谱学得以阐明。
• Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo
  作者：Yang Wang、Fei Xiong Cheng、Xiao Long Yuan、Wen Jian Tang、Jing Bo Shi、Chen Zhong Liao、Xin Hua Liu

  DOI：10.1016/j.ejmech.2016.02.009

  日期：2016.4

  It is of our interest to generate and identify novel compounds with regulation telomerase for cancer therapy. In order to carry out more rational design, based on structure-based drug design, several series of N-substituted-dihydropyrazole derivatives, totally 78 compounds as potential human telomerase inhibitors were designed and synthesized. The results demonstrated that some compounds had potent anticancer activity against four tumor cell lines, and showed good selectivity on tumor cells over somatic cells. By the modified TRAP assay, compound 13i exhibited the most potent inhibitory activity against telomerase with an IC50 value of 0.98 mu M. In vivo evaluation results indicated that compound 13i could inhibit growth of S180 and HepG2 tumor-bearing mice, and it also significantly enhanced the survival rate of EAC tumor-bearing mice. The further results in vivo confirmed that it could significantly improve pathological changes of N,N-diethylnitrosamine (DEN)-induced rat hepatic tumor. These data support further studies to assess rational design of more efficient telomerase inhibitors in the future. (C) 2016 Elsevier Masson SAS. All rights reserved.